Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
+$588M |
| 2 |
Apple
AAPL
|
+$574M |
| 3 |
Illumina
ILMN
|
+$398M |
| 4 |
argenx
ARGX
|
+$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$600M |
| 2 |
AbbVie
ABBV
|
+$323M |
| 3 |
Sherwin-Williams
SHW
|
+$309M |
| 4 |
Atlassian
TEAM
|
+$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
2501
DELISTED
NanoString Technologies, Inc.
NSTG
| $191K | ﹤0.01% |
+19,356
| New | +$191K |
|
2502
Semrush
SEMR
$1.15B
| $189K | ﹤0.01% |
+18,823
| New | +$189K |
|
2503
Grid Dynamics Holdings
GDYN
$665M
| $189K | ﹤0.01% |
+16,500
| New | +$189K |
|
2504
ON24
ONTF
$237M
| $189K | ﹤0.01% |
+21,539
| New | +$189K |
|
|
LGTY
2505
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $188K | ﹤0.01% |
+14,963
| New | +$188K |
|
2506
Mitek Systems
MITK
$456M
| $188K | ﹤0.01% |
+19,638
| New | +$188K |
|
2507
Microvision
MVIS
$334M
| $188K | ﹤0.01% |
70,582
+38,457
| +120% | +$102K |
|
|
CTIC
2508
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $187K | ﹤0.01% |
44,356
+22,079
| +99% | +$92.8K |
|
|
WSR
2509
Whitestone REIT
WSR
$661M
| $185K | ﹤0.01% |
+20,112
| New | +$185K |
|
|
ICPT
2510
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $184K | ﹤0.01% |
+13,720
| New | +$184K |
|
2511
OraSure Technologies
OSUR
$238M
| $184K | ﹤0.01% |
30,459
+15,900
| +109% | +$96.1K |
|
2512
Mercer International
MERC
$214M
| $182K | ﹤0.01% |
+18,650
| New | +$182K |
|
2513
nLIGHT
LASR
$1.42B
| $181K | ﹤0.01% |
+17,756
| New | +$181K |
|
2514
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $181K | ﹤0.01% |
26,419
+14,493
| +122% | +$99.2K |
|
2515
Allogene Therapeutics
ALLO
$253M
| $180K | ﹤0.01% |
36,433
+20,596
| +130% | +$102K |
|
2516
Flushing Financial
FFIC
$457M
| $178K | ﹤0.01% |
+11,954
| New | +$178K |
|
|
DCPH
2517
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $178K | ﹤0.01% |
+11,504
| New | +$178K |
|
2518
AngioDynamics
ANGO
$443M
| $177K | ﹤0.01% |
+17,210
| New | +$177K |
|
2519
Domo
DOMO
$621M
| $177K | ﹤0.01% |
+12,485
| New | +$177K |
|
2520
Farmers National Banc Corp
FMNB
$568M
| $177K | ﹤0.01% |
+13,983
| New | +$177K |
|
2521
Target Hospitality
TH
$873M
| $177K | ﹤0.01% |
+13,475
| New | +$177K |
|
2522
Clear Channel Outdoor Holdings
CCO
$656M
| $176K | ﹤0.01% |
147,076
+80,325
| +120% | +$96K |
|
2523
EverQuote
EVER
$866M
| $176K | ﹤0.01% |
+12,623
| New | +$176K |
|
2524
Magnachip Semiconductor
MX
$108M
| $175K | ﹤0.01% |
+18,847
| New | +$175K |
|
2525
AvePoint
AVPT
$3.51B
| $173K | ﹤0.01% |
42,088
+20,879
| +98% | +$85.9K |
|